Intimation of Closure of Trading Window as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 for the Quarter and Year Ended on 31st March 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Johnson Pharmacare Ltd has informed the stock exchanges that the trading window for dealing in its securities will remain closed for designated persons, as required under SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure is in effect for the quarter and financial year ending 31st March 2026, coinciding with the preparation and finalization of financial results. During this blackout period, insiders, directors, key managerial personnel, and other designated employees are prohibited from trading in the company's shares. This is a routine regulatory disclosure and not an event-driven announcement.
This is a standard compliance filing with no direct impact on the stock price or retail shareholders. It simply signals that the company is entering its financial results blackout period, meaning results for Q4 FY26 are expected to be announced after the window reopens.